drakecasinonodepositbonus| Pharmaceutical stocks fell collectively. Pharmaceutical centralized procurement will improve quality and expand scope, and is expected to form a national alliance for procurement

Date: 4个月前 (05-21)View: 70Comments: 0

Pharmaceutical stocks fell collectively today. As of press time, Luye Pharmaceutical (02186) fell 7.5%.drakecasinonodepositbonus.72%, quoted at HK$2.75drakecasinonodepositbonus; Kaituo Pharmaceuticals-B (09939) fell 7.35% to HK$1.26; Zhongsheng Pharmaceutical (01177) fell 5.75% to HK$2.95; Cinda Biotech (01801) fell 4.61% to HK$38.3.

drakecasinonodepositbonus| Pharmaceutical stocks fell collectively. Pharmaceutical centralized procurement will improve quality and expand scope, and is expected to form a national alliance for procurement

On the news front, according to Cailian News Agency, the National Medical Insurance Administration issued a new notice on "improving the quality and expanding the scope" of centralized procurement. Among them, many provincial-level alliance purchases are about to be upgraded to national joint procurement, which has attracted strong attention in the industry, especially the Sanming Alliance's centralized procurement of drugs for diseases such as cancer and respiratory system, and the provinces and cities involved in Henan Alternative Drugs Alliance's procurement will be further expanded.

Yang Tao, a senior executive from a listed pharmaceutical company and senior pharmaceutical industry expert, told a reporter from the Financial Union that with the issuance of the notice, the current trend of centralized procurement and full coverage of domestic routine drugs and consumables has been determined, with no dead spots or omissions. Some industry insiders told reporters from the Financial Union that in the past, the Sanming Alliance had long included generic drugs, high-value consumables, low-value consumables, IVD reagents, and even hospital equipment in the alliance's centralized procurement. The full range of categories, large span, and strict price cuts are rare in China. The industry needs to focus on studying past details and rules. In addition, Henan's centralized procurement of alternative drugs is a "price crusher" for large varieties.

Tags:

Prev: abugarcia4600c3| PricewaterhouseCoopers survey: Industries that "embrace AI" are showing a surge in productivity
Next: pvpcrypto| Minsheng Bank's first "artistic outlet" appeared in Shanghai

Related articlesNo more
︿